dc.contributor.author | Sadigh-Eteghad, S | |
dc.contributor.author | Majdi, A | |
dc.contributor.author | Talebi, M | |
dc.contributor.author | Mahmoudi, J | |
dc.contributor.author | Babri, S | |
dc.date.accessioned | 2018-08-26T05:46:14Z | |
dc.date.available | 2018-08-26T05:46:14Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41010 | |
dc.description.abstract | Nicotinic acetylcholine receptors (nAChRs) seem to play an integral role in the progress and/or prevention of Alzheimer?s diseases (AD). Functional abnormalities and problems in biogenesis and trafficking of nAChRs are two major culprits in AD; on the other hand, chaperones modulate post-translational changes in nAChRs. Moreover, they indirectly regulate nAChRs by controlling AD-related proteins such as tau and amyloid beta (A?). In this review, we go through recent studies which are showing that chaperones modulate the expression of nAChRs in a subtype-specific manner and explain how AD progress is affected by nAChRs chaperoning. | |
dc.language.iso | English | |
dc.relation.ispartof | European journal of pharmacology | |
dc.subject | Alzheimer Disease | |
dc.subject | Brain | |
dc.subject | Humans | |
dc.subject | Molecular Chaperones | |
dc.subject | Receptors, Nicotinic | |
dc.title | Regulation of nicotinic acetylcholine receptors in Alzheimer?s disease: a possible role of chaperones. | |
dc.type | article | |
dc.citation.volume | 755 | |
dc.citation.spage | 34 | |
dc.citation.epage | 41 | |
dc.citation.index | Pubmed | |
dc.identifier.DOI | https://doi.org/10.1016/j.ejphar.2015.02.047 | |